INmune Bio, Inc. (INMB) Free Cash Flow
INmune Bio, Inc. (INMB) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2018-12-31 | -$2.06M |
| 2019-12-31 | -$5.38M |
| 2020-12-31 | -$8.94M |
| 2021-12-31 | -$43.50M |
| 2022-12-31 | -$22.69M |
| 2023-12-31 | -$12.00M |
| 2024-12-31 | -$33.40M |
| 2025-12-31 | -$23.64M |
How INMB compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| HSDT | Helius Medical Technologies Inc. | -$16.51M |
| RFL | Rafael Holdings Inc. Class B | -$18.95M |
| HRTX | Heron Therapeutics Inc. | -$27.91M |
| ENTA | Enanta Pharmaceuticals Inc. | -$32.17M |
| ALDX | Aldeyra Therapeutics Inc. | -$33.35M |
These are five companies in the same sector as INMB with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get INmune Bio, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("INMB", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | INMB | $2.36 | +1.72% | 0.45M |
| 3 | ||||
| 4 | ||||
| 5 |